Tanja Djukic

At Zentiva, we are intensifying our focus on biosimilar medicines to make high-quality, affordable healthcare more accessible for millions of people.   Biosimilars are highly similar to existing biologic medicines, offering the same safety, quality, and effectiveness, at lower cost. By increasing our focus in this space, we’re helping healthcare systems become more sustainable and ensuring that more patients can access the treatments they need.   This initiative diversifies Zentiva's development pipeline, strengthens our position in the European pharmaceutical market and opens up new opportunities for collaboration.   Martin Albert, Zentiva’s Chief Scientific Officer, said: "We are intensifying our focus on biosimilars because we believe they are essential to the future of healthcare. This is not just about expanding our portfolio, it’s about expanding access. Our teams are united in purpose, and together we’re building a future where affordability and quality go hand in hand."   #Zentiva #Biosimilars #HealthcareAccess #HealthForAll

206

1 komentarz

Clinical laboratory technicians need to interpret test results while managing their busy daily tasks and staying up to date with the latest information and diagnostic guidelines. At Sysmex, our #ApplicationSupport activities create an environment where technicians can focus on interpreting results and reporting them to doctors by offering academic information backed by our extensive knowledge and expertise. Discover how our Application Support efforts are creating new value in testing and addressing healthcare challenges 👇 https://lnkd.in/dwbuHDYV #QualityService #CustomerSatisfaction #anshin #SysmexStories

106

Did you miss the human medicines highlights for 2024? A record 114 medicines were recommended, highlighting advancements in various therapeutic areas, including oncology, immunology, and endocrinology. This report provides an overview into the latest developments in innovative treatments and biosimilars, which aim to improve patient access to vital therapies.  Learn more and download the full report 👉 https://lnkd.in/ervmyQMG #EMA #HumanMedicines #Pharmaceutical #Healthcare #Innovation

380

14 komentarzy

We are leveraging our deep expertise in drug discovery and disease biology to research potential treatments for pulmonary fibrosis and other pulmonology diseases with high unmet needs. We look forward to participating at the European Respiratory Society Annual Congress where we’ll be presenting data that enhance our understanding of the patient experience in progressive pulmonary fibrosis (PPF) and the latest from our clinical program in idiopathic pulmonary fibrosis (IPF). Learn more about our work in pulmonology: https://bit.ly/46qrnvO #ERSCongress #OneBMS

131

4 komentarze